Table 5.

Recommended Surveillance for Individuals with 17q12 Recurrent Duplication

Development Monitor developmental progress & educational needs.At each visit
Assessment for anxiety, attention, & aggressive or self-injurious behavior
  • Assess for new seizures.
  • Monitor those w/seizures as clinically indicated.
  • Measurement of growth parameters
  • Eval of nutritional status & safety of oral intake
Eyes Ophthalmology examFrequency as recommended by ophthalmologist
Endocrine Monitor for signs/symptoms of endocrinologic disorders; evaluate as needed.At each visit
Assess family need for social work support (e.g., palliative/respite care, home nursing, other local resources) & care coordination.

From: 17q12 Recurrent Duplication

Cover of GeneReviews®
GeneReviews® [Internet].
Adam MP, Feldman J, Mirzaa GM, et al., editors.
Seattle (WA): University of Washington, Seattle; 1993-2024.
Copyright © 1993-2024, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.

GeneReviews® chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source ( and copyright (© 1993-2024 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the GeneReviews® Copyright Notice and Usage Disclaimer. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.

For more information, see the GeneReviews® Copyright Notice and Usage Disclaimer.

For questions regarding permissions or whether a specified use is allowed, contact: ude.wu@tssamda.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.